Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Christina LeitzenTimo Wilhelm-BuchstabSabina StumpfMartina HeimannDavid KochChristopher SchmeelBirgit SimonSusanne VornholtStephan GarbeFred RöhnerFelix SchorothHans Heinz SchildHeinrich SchüllerThomas MüdderPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2019)
With helical tomotherapy, postoperative treatment for malignant pleural mesothelioma after pleurectomy achieves good target coverage combined with simultaneous dose sparing to the (especially contralateral) OARs.